Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04847284 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intraoperative Radiotherapy in Patients With Brain Metastases

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 6, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Mar 2025 to Dec 2025v4
  2. Primary completion date: Mar 1, 2024 to Mar 2025
    • Start date: Jan 1, 2021 to May 5, 2021
    • Study completion date: Mar 1, 2024 to Dec 2025
    v3
  3. Study site revised
    • Eligibility criteria expanded, about 4 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Intraoperative radiotherapy (IORT) is a new alternative for local radiotherapy with the advantages of dose escalation, reduced overall treatment time, and enhanced patient convenience, however the degree of efficacy is unknown, as well as and which is the most efficient dose. The objective of this study is to evaluate the efficacy and safety of IORT in patients with surgical excision of brain metastases at a dose of 20 Gy is at least as effective and safe as other forms of radiation therapy in patients with resection of brain metastases.
Trial Details
NCT Number NCT04847284
Lead Sponsor Parc de Salut Mar
Conditions
(from sponsor)		 Brain Metastases
Related terms Brain Neoplasms
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov